0000899243-20-032920.txt : 20201207
0000899243-20-032920.hdr.sgml : 20201207
20201207200527
ACCESSION NUMBER: 0000899243-20-032920
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201204
FILED AS OF DATE: 20201207
DATE AS OF CHANGE: 20201207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shah Vinay
CENTRAL INDEX KEY: 0001753078
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36361
FILM NUMBER: 201374138
MAIL ADDRESS:
STREET 1: C/O VERSARTIS, INC.
STREET 2: 1020 MARSH ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aravive, Inc.
CENTRAL INDEX KEY: 0001513818
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264106690
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: RIVER OAKS TOWER
STREET 2: 3730 KIRBY DRIVE, SUITE 1200
CITY: HOUSTON
STATE: TX
ZIP: 77098
BUSINESS PHONE: 936-355-1910
MAIL ADDRESS:
STREET 1: RIVER OAKS TOWER
STREET 2: 3730 KIRBY DRIVE, SUITE 1200
CITY: HOUSTON
STATE: TX
ZIP: 77098
FORMER COMPANY:
FORMER CONFORMED NAME: Versartis, Inc.
DATE OF NAME CHANGE: 20110223
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-04
0
0001513818
Aravive, Inc.
ARAV
0001753078
Shah Vinay
C/O ARAVIVE, INC., RIVER OAKS TOWER,
3730 KIRBY DRIVE, SUITE 1200
HOUSTON
TX
77098
0
1
0
0
Chief Financial Officer
Common Stock
2020-12-04
4
P
0
8000
5.76
A
189842
D
The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $5.73 to $5.79, inclusive. The reporting person undertakes to provide Aravive, Inc., any security holder of Aravive, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
Includes an aggregate of 3,236 shares acquired under the Aravive, Inc. 2014 Employee Stock Purchase Plan, of which 416 shares were acquired on each of May 15, 2019, November 15, 2019 and May 15, 2020, respectively and 1,988 shares were acquired on November 13, 2020.
/s/ Abel Svitavsky, Attorney-in-fact
2020-12-07